Sales came in as expected at $187 million flat to the prior quarter and down 15% organically.
The $45 million cost plan for 2020 that we communicated in May remains on track.
With 13 new product launches in Q3, we remain on track to deliver on our commitment to launching 45 new products this year.
Commercial revenue is expected to grow sequentially between 15% and 25%, but we'll be down year over year between 40% and 45%.
The $45 million cost plan for 2020 is on track.
We remain on track to deliver on our commitment to launching a record of 45 new products this year.
